相关实验视频

Updated: May 17, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

HLA多态性和COVID-19易感性和严重性:来自伊朗患者队列的见解

Pooria Hakimi¹, Kasra Arbabi Zaboli¹, Mohammadreza Golbabapour-Samakoush¹

¹Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

Journal of cellular and molecular medicine

|May 14, 2025

概括

人类白细胞抗原 (HLA) 基因变异影响COVID-19的易感性和严重程度. 特定的HLA等位基因与增加的风险和更糟糕的结果有关,这表明患者的免疫反应有差异.

科学领域:

免疫遗传学免疫遗传学
传染病流行病学传染病流行病学

背景情况:

人类白细胞抗原 (HLA) 系统对于针对SARS-CoV-2等病原体的免疫反应至关重要.
在HLA基因中的遗传变异 (多态) 可能会影响个体的易感性和COVID-19的严重程度.

研究的目的:

调查HLA多态性和对COVID-19的易感性之间的关联.
探索特定的HLA等位基因与COVID-19疾病严重程度之间的关系.

主要方法:

招募了290名住院的伊朗COVID-19患者 (160名中度,130名重度).
在低分辨率使用PCR-SSP分析了HLA类I (HLA-A,HLA-B,HLA-C) 和类II (HLA-DRB1,HLA-DQB1) 的多态性.

主要成果:

已确定与COVID-19易感性相关的HLA等位基因 (HLA-B*49,HLA-B*52,HLA-C*12,HLA-DRB1*04,HLA-DQB1*05) 已经被确定.
发现HLA-A*23,HLA-DRB1*10和HLA-DRB1*13等同基因与疾病严重程度的增加有关.
观察到HLA-A*23载体的淋巴细胞数量减少和血栓形成风险增加,这可能表明免疫反应不适应.

结论:

特定的HLA多态性与COVID-19的易感性和严重性显著相关.
HLA-A*23等位基因可能通过诸如细胞因子风暴和淋巴细胞亡等机制导致严重的COVID-19结果.
这些发现突显了免疫遗传学在确定个人对SARS-CoV-2感染的反应中的作用.

关键词:

根据COVID-19的情况,对于HLA-A抗原来说,对于HLA-B抗原来说,这是一个很大的问题.在HLA-C抗原中,在HLA-DR抗原中,

更多相关视频

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...